(Q39492668)

12 September 2017

Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin (English)

1 reference

12 September 2017

S Moncada

1

1 reference

PubMed ID

78050

12 September 2017

R Korbut

series ordinal

2

1 reference

PubMed ID

78050

12 September 2017

language of work or name

English

0 references

publication date

1 June 1978

1 reference

12 September 2017

1 reference

12 September 2017

1

1 reference

12 September 2017

8077

1 reference

12 September 2017

1286-1289

1 reference

Effect of dipyridamole on human platelet behaviour.

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991269-2

7 January 2021

Effect of a Pyrimidopyrimidine Derivative on Thrombus Formation in the Rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991269-2

7 January 2021

Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991269-2

7 January 2021

The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991269-2

7 January 2021

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991269-2

7 January 2021

Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991269-2

7 January 2021

Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991269-2

7 January 2021

Modulation of human platelet adenylate cyclase by prostacyclin (PGX)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991269-2

7 January 2021

The effect of salicylates on the hemostatic properties of platelets in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991269-2

7 January 2021

Acetylation of prostaglandin synthase by aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991269-2

7 January 2021

Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991269-2

7 January 2021

An antiserum to 5,6-dihydro prostacyclin (PGI1) which also binds prostacyclin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991269-2

7 January 2021

Synthesis and sterochemistry of prostacyclin and synthesis of 6-ketoprostagliandin F1alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991269-2

7 January 2021

Inhibition of prostaglandin synthesis in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991269-2

7 January 2021

Inhibition of platelet prostaglandin synthetase by oral aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991269-2

7 January 2021

Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991269-2

7 January 2021

Effect of dipyridamole and aspirin in thrombotic microangiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991269-2

7 January 2021

Platelet and fibrinogen consumption in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2991269-2

7 January 2021

10.1016/S0140-6736(78)91269-2

Identifiers

DOI

1 reference

12 September 2017

1 reference

PubMed ID

78050